ClinicalTrials.gg
RecruitingNCT07750080RCTUpdated Aug 6, 2026

The Effect of Multimodal Approach of Electrotherapy Versus Shock Wave Therapy in Menopausal Women With Tennis Elbow.

An interventional study of multimodal electrotherapy and shock wave therapy in Shock Wave, sponsored by October 6 University. Recruiting at 1 site in Egypt. Open to female participants aged 45 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by October 6 University · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Mar 2026, registered Jul 2026).
  • Started Mar 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
45 Years to 55 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 11 studies in Tennis Elbow with a site in Egypt — 4 open to participants now, 4 under way, none of them phase 3. Tennis Elbow · Egypt.

Planned enrollment
9th of 11
45 · median 60
Started
2026
the only one that year
No phase
10 of 11
3 open now
Registered
11th of 11
by date
Lead sponsor
3 of 11
October 6 University

Among the 11 studies in Tennis Elbow with a site in Egypt, this one is the 9th largest by planned enrollment, is the only one that started in 2026, is one of 10 with no phase, and was the 11th registered.

Tennis Elbow

296 studies on the registry are indexed under Tennis Elbow; 64 are open to participants now.

Browse Tennis Elbow studies →

Open to participants now

4 of the 11 studies in Tennis Elbow with a site in Egypt are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 42 Tennis Elbow studies recruiting now, 8 (19%) set no upper age limit and 31 (74%) stop at 75 or younger; 1 take children under 18; 5 take healthy volunteers.

This study: 45 Years to 55 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Tennis Elbow with a site in Egypt, or all of them as a file.
02

Study summary

Tennis Elbow (or Lateral Epicondylalgia) is one of the most common overload injuries that it is the most frequent cause of lateral elbow pain, occurring to people between 40-60 years of age. It is characterized by pain on the outside of the elbow, usually near the lateral epicondyle bone where the extensor carpi Brevis tendon attaches, aggravated by gripping or wringing activities During menopause period, declining estrogen levels can negatively impact tendon health. Estrogen plays a protective role in tendons, contributing to their strength and ability to withstand load.

Read the detailed description

As estrogen decreases, tendons may become weaker, less resilient, and more susceptible to injury, potentially leading to conditions like tendinopathy. This can often add to these feelings of pain and limit of function ; and possibly limit your movements in day to day activities. Multimodal electrotherapy ( low level laser therapy plus interferential current) and extracorporeal shock wave therapy can be used to improve this problem.

03

Conditions studied

  • Shock Wave

Browse trials for

Keywords

  • tennis elbow
04

Who can participate

Ages eligible
45 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

1) forty five menopausel females suffer from chronic lateral epicondylitis from Department of out patient orthopedic clinic of 6 october hospital .

(2) Their age ranged from 45 _55 years old 3) Their will be 18.5 to 24.9 kg/m2. 4) Point tenderness at the lateral epicondyle. 5) Positive Cozen test 6) Symptoms duration of minimum 3 months

Exclusion criteria

Exclusion Criteria:

  1. Patients with cervical radiculopathy ,thoracic outlet syndrome ,
  2. dysfunction in shoulder or elbow with injection in previous three months.
  3. Their more than 25 kg/m2.
  4. Unrelated to any traumatic conditions
  5. Any previous fracture elbow, wrist or hand

    -

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Single group
Masking
Single (Participant)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    Group A

    It consisted of fifteen menopause women receive the multimodal electrotherapy ( low level laser therapy and interferential current ) with conventional physical therapy as form of stretching and strengthen exercise

    Other: multimodal electrotherapy

  • Experimental
    Group B

    It consisted of fifteen menopause women receive receives extracorporeal shock wave therapy with conventional physical therapy

    Other: shock wave therapy

  • Experimental
    Group C

    It consisted of fifteen menopause women receive conventional physical therapy

    Other: exercise

Interventions

  • Othermultimodal electrotherapy

    subjects will receive multimodal approach of electrotherapy (LLLT , and IFC) with conventional physical therapy modalities in the form of (stretch and strengthen exercises ) 3 sessions every week for 6 weeks

  • Othershock wave therapy

    subjects will receive shock wave therapy with conventional physical therapy modalities 3 sessions every week for 6 weeks.

  • Otherexercise

    subjects will receive with conventional physical therapy modalities only in the form of (stretching and strengthening therapeutic exercises ) 3 sessions every week for 6 weeks.

06

What researchers measure

Primary outcomes

  1. Visual analogue scale

    The VAS consists of a 10-cm line, with the left extremity indicating ''no pain'' and the right extremity indicating ''unbearable pain.'' Participants asked to use the scale to indicate their current level of pain Higher values suggest more intense pain ,It was found that VAS provide valid and reliable assessments for the affective magnitude, as well as the sensation intensity of pain.

    Time frame: 6 weeks

  2. hand grip

    Grip hand strength will be assessed by hand held dynamometer

    Time frame: 6 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Aug 2026, 5 months after the start.

Of 152 non-industry interventional studies with no phase under Tennis Elbow, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 5 months is below that.

Counting every sponsor, half of 154 studies reached it within 8 months; a quarter within 5 and three quarters within 22.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2026
First posted
Aug 6, 2026
StartActual
Mar 3, 2026
Primary completionEst.
Aug 3, 2026
CompletionEst.
Sep 1, 2026
Last update
Aug 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07750080
Responsible party
heba Haridy (lecturer of basic science department, October 6 University) — Principal investigator
First posted
Aug 6, 2026
Start date
Mar 3, 2026
Primary completion
Aug 3, 2026 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
Aug 6, 2026

Study contacts

Heba ahmed, doctoral
Contact
Heba.Ahmed.PT@o6u.edu.eg
01117671712
Menna Mohmed, doctoral
Contact
Mennamohmed.PT@o6u.edu.eg
01118758578

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion